All posts

Sabio set to go public

U.S.-based Ad tech company Sabio, which will be known as Sabio Holdings Inc,  is about to hit the public markets with an aim to bring its connected TV advertising solutions to a wider audience. 

Sabio announced on Monday the completion of its qualifying transaction, a reverse takeover with Spirit Banner II Capital Corp, which paves the way to commence trading on Friday on the TSX Venture Exchange under the ticker “SBIO.”

Founded in 2015, Los Angeles-based Sabio is a CTV platform business that uses mobile phone-based data, device location and user behaviour to help companies and brands in targeting their ad campaigns. 

Sabio is headed by CEO Aziz Rahimtoola, formerly SVP at Opera Mediaworks and with prior roles as a director at AT&T’s Adworks and NBC Universal. Rahimtoola said Sabio’s platform is invested in what they call “app science” to give companies better insight into consumer behaviour.

“I’ve spent a number of years at various media companies and in those journeys what I realized is the need to provide a deeper understanding of the consumer and specifically an understanding from the in-app mobile perspective,” said Rahimtoola, speaking on BeetTV earlier this year. “When we first started the company we set out to really focus in on that element relative to boiling the ocean — we really wanted to hone in on user behaviour as it relates to app behaviour.”

Rahimtoola says there’s a lot of ground to be mined in the space between mobile phones and connected TV.

“What we like to say is an app is an app, so regardless if the app is on your phone or on your TV it’s an app. What Sabio and app science are focusing on providing deeper unique targeting reach and capabilities. And then, along with creative capabilities, to provide agnostic analytics and insights on CTV and OTT along with mobile campaigns,” he said.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

20 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

21 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

21 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

1 day ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago